Original Research
Published on 28 Jan 2021
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
in Cancer Immunity and Immunotherapy
- 10,411 views
- 19 citations
Original Research
Published on 28 Jan 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 12 Nov 2021
in Molecular and Cellular Pathology
Mini Review
Published on 12 Aug 2021
in Molecular Innate Immunity
Original Research
Published on 08 Dec 2020
in Immunological Tolerance and Regulation
Original Research
Published on 16 Apr 2021
in Inflammation
Original Research
Published on 19 Feb 2026
in Alloimmunity and Transplantation
Original Research
Published on 22 Jul 2021
in Cancer Immunity and Immunotherapy
Review
Published on 20 Aug 2021
in Cancer Immunity and Immunotherapy
Original Research
Published on 28 Oct 2022
in Cytokines and Soluble Mediators in Immunity